scholarly article | Q13442814 |
P50 | author | Filippo Martignano | Q50935945 |
Flavia Foca | Q52958617 | ||
Samanta Salvi | Q57077641 | ||
Giorgia Gurioli | Q86590574 | ||
Valentina Casadio | Q87983305 | ||
Ugo De Giorgi | Q88923334 | ||
Matteo Costantini | Q96254230 | ||
Daniele Calistri | Q38641368 | ||
P2093 | author name string | Roberta Gunelli | |
P2860 | cites work | Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines | Q27853038 |
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells | Q28363395 | ||
Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis | Q33909418 | ||
Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death | Q34123770 | ||
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. | Q34249360 | ||
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis | Q35108310 | ||
Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysis | Q35678704 | ||
Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies. | Q35846508 | ||
Molecular detection of prostate cancer: a role for GSTP1 hypermethylation | Q35913110 | ||
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis | Q35933390 | ||
Epigenetic markers for molecular detection of prostate cancer | Q36746201 | ||
The epigenetic promise for prostate cancer diagnosis | Q37967574 | ||
DNA methylation changes in prostate cancer. | Q37987501 | ||
Glutathione S-transferase-pi protein expression in prostate cancer--not always a useful diagnostic tool | Q56970331 | ||
CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker | Q73418972 | ||
High-grade prostatic intraepithelial neoplasia | Q80295827 | ||
Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens | Q85781880 | ||
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies? | Q38100547 | ||
The study of DNA methylation in urological cancer: present and future. | Q38104113 | ||
Cancer development, progression, and therapy: an epigenetic overview. | Q38154977 | ||
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference | Q38230103 | ||
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death | Q38241806 | ||
Meta-analyses of methylation markers for prostate cancer | Q39155363 | ||
GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma | Q39449319 | ||
Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer | Q40890580 | ||
Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy | Q41207861 | ||
Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle biopsy | Q42470183 | ||
Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer | Q44108405 | ||
Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia | Q47242342 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 4358292 | |
P577 | publication date | 2016-08-10 | |
P1433 | published in | Disease Markers | Q15756044 |
P1476 | title | GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications | |
P478 | volume | 2016 |
Q98178219 | Aberrant SOCS3 Promoter Methylation as a Noninvasive Diagnostic Biomarker for Locally Advanced Prostate Cancer |
Q92133146 | Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk |
Q99591000 | Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research |
Q90459573 | Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer |
Q60534631 | GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity |
Q90397374 | GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk |
Q52728695 | High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma. |
Q42687929 | Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis |
Q92211919 | Racial disparities, cancer and response to oxidative stress |
Q89637860 | Targeted nanopore sequencing with Cas9-guided adapter ligation |
Q47379977 | The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? |
Q49546811 | The molecular biology of prostate cancer: current understanding and clinical implications |
Search more.